According to a study from the United States, The purpose of this study was to evaluate contrast- enhanced ultrasound and neural network data classification for determining the breast cancer response to bevacizumab therapy in a murine model. An ultrasound scanner operating in the harmonic mode was used to measure ultrasound contrast agent (UCA) time-intensity curves in vivo.















Recent comments
3 years 34 weeks ago